AbbVie Recalls Duopa Carbidopa and Levodopa Cassettes for Stability Issues
AbbVie is recalling Duopa (carbidopa and levodopa) cassettes because stability testing showed the drug may settle near the end of its shelf life.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text explicitly identifies the recall as FDA Class II. Per the rubric, FDA Class II recalls are classified as Severe (Score 4), particularly when the defect involves a significant deviation from specifications that could impact drug efficacy or safety.
Plain-English summary
AbbVie Inc. is recalling specific lots of Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL cassettes. The recall involves 4,021 cartons, each containing seven 100-mL cassettes. The affected lots were distributed in Tennessee and Illinois.
The recall was initiated because confirmed out-of-specification results were obtained during refrigerated material stability testing. These results indicate that the drug may settle within the drug cassettes as they near the end of their refrigerated shelf life. The agency has classified this as a Class II recall.
Patients and healthcare providers should stop using the affected cassettes and contact their healthcare provider or pharmacist for instructions on how to obtain a replacement. The specific lot numbers and expiration dates are listed in the official recall notice.
The recalled product
- Product
- DUOPA (CARBIDOPA AND LEVODOPA)
- Brand
- DUOPA
- Manufacturer
- AbbVie Inc.
- Category
- Drug — Prescription Drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lots: 1055692
- Expiration Date (Frozen) 06/01/2018 1057881
- Expiration Date (Frozen) 06/02/2018 1060138
- Expiration Date (Frozen) 06/13/2018 1060140
- Expiration Date (Frozen) 06/15/2018 1061258
- Expiration Date (Frozen) 06/17/2018 1061262
- Expiration Date (Frozen) 06/30/2018 1063033
- Expiration Date (Frozen) 07/14/2018
UPCs (1)
- 0300743012071
Distribution
Related recalls
Same manufacturer · AbbVie Inc.
See all →- ModeratePred Mild prednisolone eye suspension failed stability specifications
FDA (Drugs) · 2026-06-03
- HighRefresh LACRI-LUBE Eye Ointment Recalled for Potential Tube Seal Breach
FDA (Drugs) · 2024-10-02
- HighFDA Recalls Refresh P.M. Eye Ointment Due to Potential Sterility Breach
FDA (Drugs) · 2024-10-02
- HighSynthroid Levothyroxine Tablets Recalled for Incorrect Barcode Labeling
FDA (Drugs) · 2023-11-15
- LowAbbVie Recalls Ultane Sevoflurane Due to Defective Container Caps
FDA (Drugs) · 2018-02-07
Same hazard · stability failure
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateVasocaine lidocaine spray recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateZone 1 lidocaine cream recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateZone 2 lidocaine cream recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateCiclopirox shampoo recalled after failing impurity specifications at eighteen months
FDA (Drugs) · 2025-12-24